Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin

Arq Neuropsiquiatr. 2020 Jan;78(1):58-59. doi: 10.1590/0004-282X20190109.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Blepharospasm / chemically induced
  • Blepharospasm / drug therapy*
  • Botulinum Toxins / therapeutic use*
  • Edema / chemically induced
  • Edema / drug therapy*
  • Humans
  • Imatinib Mesylate / adverse effects*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Male
  • Orbital Diseases / chemically induced
  • Orbital Diseases / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Imatinib Mesylate
  • Botulinum Toxins